<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02519465</url>
  </required_header>
  <id_info>
    <org_study_id>Luciana doutorado 02</org_study_id>
    <nct_id>NCT02519465</nct_id>
  </id_info>
  <brief_title>Evaluation of Lung Deposition of Aerosol Via HFNC in Healthy Adults</brief_title>
  <official_title>Evaluation of Lung Deposition of Aerosol Via HFNC in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal de Pernambuco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal de Pernambuco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aerosol associated with noninvasive ventilation (NIV) and high flow therapy with nasal
      interface have been employed in an attempt to relieve respiratory distress and optimize the
      deposition of drugs by inhalation.

      Some studies report the effects of NIV association with fogging in healthy subjects,
      asthmatics and COPD 7.8, but studies evaluating the association between high flow nasal mist
      interface and therapy are scarce and most are found in vitro and animal models. The objective
      of this study is to evaluate the deposition of the aerosol scintigraphy using the high flow
      nasal interface system with vibrating mesh nebulizers using in healthy adults.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>radioaerosol deposition index into the lungs</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>HEATED FLOW</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The volunteers were randomly allocated into three groups - group 1 - 10l/min cold or heated, group 2 - 30l/min cold or heated, group 3 - 50 l /min - cold or heatedPhase 1 - 10l/min or 30l/min or 50l/min of the oxygen heated .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COLD FLOW</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The volunteers were randomly allocated into three groups - group 1 - 10l/min cold or heated, group 2 - 30l/min cold or heated, group 3 - 50 l /min - cold or heatedPhase 1 - 10l/min or 30l/min or 50l/min of the oxygen cold</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>10l/min</intervention_name>
    <description>For inhalation was used diethilene penta-acetic triamine technetium (99mTc-DTPA) with radioactivity of 1 millicuries (Noble et al., 2007) and 0.9% saline solution with a total volume of 1 ml using vibrating mesh inhaler (Aerogen Ltd, Galway , Ireland) with the respiratory care system for the high flow ( Fisher &amp; Paykel healthcare, New Zealand) and nasal cannula (Fisher &amp; Paykel healthcare, New Zealand) with flow 10l/min</description>
    <arm_group_label>HEATED FLOW</arm_group_label>
    <arm_group_label>COLD FLOW</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>30l/min</intervention_name>
    <description>For inhalation was used diethilene penta-acetic triamine technetium (99mTc-DTPA) with radioactivity of 1 millicuries (Noble et al., 2007) and 0.9% saline solution with a total volume of 1 ml using vibrating mesh inhaler (Aerogen Ltd, Galway , Ireland) with the respiratory care system for the high flow ( Fisher &amp; Paykel healthcare, New Zealand) and nasal cannula (Fisher &amp; Paykel healthcare, New Zealand) with flow 30l/min.</description>
    <arm_group_label>HEATED FLOW</arm_group_label>
    <arm_group_label>COLD FLOW</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>50l/min</intervention_name>
    <description>For inhalation was used diethilene penta-acetic triamine technetium (99mTc-DTPA) with radioactivity of 1 millicuries (Noble et al., 2007) and 0.9% saline solution with a total volume of 1 ml using vibrating mesh inhaler (Aerogen Ltd, Galway , Ireland) with the respiratory care system for the high flow ( Fisher &amp; Paykel healthcare, New Zealand) and nasal cannula (Fisher &amp; Paykel healthcare, New Zealand) with flow 50l/min.</description>
    <arm_group_label>HEATED FLOW</arm_group_label>
    <arm_group_label>COLD FLOW</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The study included healthy individuals of both sexes,

          -  between 18 to 65 years,

          -  without history of lung disease and forced vital capacity (FVC) or forced expiratory
             volume in the first second (FEV1) higher or equal to 80% from predicted values,

          -  ability to verbal commands understand and

          -  willing to provide signed consent to participate in this study.

        Exclusion Criteria:

          -  Participants were excluded if there unable to understand and follow the procedures and
             were pregnant and unable to tolerate nebulization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luciana Alcoforado, MsC</last_name>
    <role>Principal Investigator</role>
    <affiliation>UFPE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniella C Brandao, PhD</last_name>
    <phone>+558121268496</phone>
    <email>daniellacunha@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Armele F Dornelas de Andrade, PhD</last_name>
    <phone>+558121268496</phone>
    <email>armeledornelas@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Laborat√≥rio de Fisiologia e Fisioterapia Cardiopulmonar</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luciana Alcoforado</last_name>
      <email>lucalcoforado@yahoo.com.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2015</study_first_submitted>
  <study_first_submitted_qc>August 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2015</study_first_posted>
  <last_update_submitted>August 10, 2015</last_update_submitted>
  <last_update_submitted_qc>August 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Pernambuco</investigator_affiliation>
    <investigator_full_name>Daniella Cunha Brandao</investigator_full_name>
    <investigator_title>Luciana Alcoforado Mendes da Silva</investigator_title>
  </responsible_party>
  <keyword>nasal cannula</keyword>
  <keyword>Inhalation Devices</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

